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GYNGYN alternative splicing <p>Computational and experimental evidence is given for alternative splicing at the unusual GYNGYN motif in several species, enabling  in most cases subtle protein variations.</p>
Abstract
Background: Splice donor sites have a highly conserved GT or GC dinucleotide and an extended
intronic consensus sequence GTRAGT that reflects the sequence complementarity to the U1
snRNA. Here, we focus on unusual donor sites with the motif GYNGYN (Y stands for C or T; N
stands for A, C, G, or T).
Results: While only one GY functions as a splice donor for the majority of these splice sites in
human, we provide computational and experimental evidence that 110 (1.3%) allow alternative
splicing at both GY donors. The resulting splice forms differ in only three nucleotides, which results
mostly in the insertion/deletion of one amino acid. However, we also report the insertion of a stop
codon in four cases. Investigating what distinguishes alternatively from not alternatively spliced
GYNGYN donors, we found differences in the binding to U1 snRNA, a strong correlation between
U1 snRNA binding strength and the preferred donor, over-represented sequence motifs in the
adjacent introns, and a higher conservation of the exonic and intronic flanks between human and
mouse. Extending our genome-wide analysis to seven other eukaryotic species, we found
alternatively spliced GYNGYN donors in all species from mouse to Caenorhabditis elegans and even
in Arabidopsis thaliana. Experimental verification of a conserved GTAGTT donor of the STAT3 gene
in human and mouse reveals a remarkably similar ratio of alternatively spliced transcripts in both
species.
Conclusion:  In contrast to alternative splicing in general, GYNGYN donors in addition to
NAGNAG acceptors enable subtle protein variations.
Background
Given the rather limited number of human genes [1], alterna-
tive splicing is believed to be a major mechanism to bridge the
gap between the gene and protein number [2,3]. Most human
multi-exon genes express more than one splice variant [4].
Protein isoforms, produced by alternative splicing, can differ
Published: 25 July 2006
Genome Biology 2006, 7:R65 (doi:10.1186/gb-2006-7-7-r65)
Received: 3 April 2006
Revised: 19 May 2006
Accepted: 25 July 2006
The electronic version of this article is the complete one and can be 
found online at http://genomebiology.com/2006/7/7/R65R65.2 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. http://genomebiology.com/2006/7/7/R65
Genome Biology 2006, 7:R65
in various aspects, including ligand binding affinity, signaling
activity, protein domain composition, subcellular localiza-
tion, and protein half-life [5]. In coordination with nonsense-
mediated mRNA decay, alternatively spliced transcripts can
be degraded rapidly, providing a regulation and fine-tuning
mechanism of the adjustment of the protein level [6].
The skipping of an exon is the most frequent alternative splice
event, followed by alternative splice donor and acceptor sites
[7]. Such splice events often result in large effects for the pro-
teins, for example, by deleting functional units like protein
domains [8,9] or transmembrane helices [10,11]. On the other
hand, alternative splicing also allows the production of many
very similar protein isoforms. The most frequent of these sub-
tle events is the alternative splicing at NAGNAG or tandem
acceptors [12]. In the NAGNAG motif (N stands for A, C, G or
T/U; throughout the paper we write T instead of U also when
referring to an RNA sequence), we have termed the upstream
acceptor the E acceptor (since the downstream NAG becomes
exonic in case of splicing at this site) and the downstream one
the I acceptor (since the whole tandem becomes intronic).
This splice acceptor motif frequently allows the selection of
one of the two AGs in the splice process, resulting in the inser-
tion/deletion (indel) of the I acceptor NAG in mRNAs, prefer-
ably if both Ns are either A, C, or T [13-15]. Despite the rather
simple genomic structure, these NAG indels lead to a surpris-
ingly high diversity at the protein level. Depending on the
sequence of the up- and downstream exon and the phase of
the intron, eight different single amino acid indels, the
exchange of a dipeptide for an unrelated amino acid, and the
indel of a stop codon are possible [12]. These subtle protein
changes can result in functional differences for the respective
protein isoforms [15-18].
The recognition of donor and acceptor splice sites is different.
While the acceptor AG and its preceding polypyrimidine tract
is recognized by the U2AF heterodimer [19], the donor site
has an extended consensus sequence AG|GTRAGT (| is the
splice site, R stands for A or G), that is bound by base pairing
to the 5' end of the U1 snRNA [20]. However, two donor sites
that are only three nucleotides (nt) apart would result in over-
lapping U1 snRNA binding sites and the GTNGTN motif dif-
fers from the donor consensus sequence at the two conserved
positions +4 and +5. According to the consensus, an alterna-
tive usage of the GT dinucleotide 4 nucleotides downstream is
much more likely but results in a frameshift and thus a dra-
matic change of the protein if the donor is located in the cod-
ing sequence (CDS).
Here we investigate whether alternative splicing at a GT or GC
donor dinucleotide 3nt up- or downstream is possible. This
type of alternative splicing requires a GYNGYN donor motif
(Y stands for C or T) and is of interest because it would result
in similar subtle protein changes like at NAGNAG tandem
acceptors and thus increase the proteome plasticity. We
found expressed sequence tag (EST) and/or mRNA evidence
for alternative splicing at 110 human GYNGYN tandem
donors and confirm the existence of both splice forms by RT-
PCR experiments in seven cases. We report the occurrence of
alternative splicing at GYNGYN tandem donors in six other
animals and a plant. Analyzing the GYNGYN motifs that do
and do not allow alternative splicing, we found significant dif-
ferences in the stability of the U1 snRNA binding, conserved
exonic and intronic flanks between human and mouse, and
over-represented sequence motifs in the intronic flanks.
Results
Alternative splicing at tandem donor sites
Although the great majority of introns begins with a GT dinu-
cleotide, a small fraction of 0.76% begins with GC [1]. To
investigate whether splice donor sites with the pattern GYN-
GYN allow the usage of both potential splice sites in humans,
we first retrieved from the UCSC Human Genome Browser
(hg17, May 2004) all RefSeq-to-genome alignments. Given
the exon-intron structure of those transcripts, we extracted a
9 nucleotide sequence (3 exonic and 6 intronic nt; -3 to +6, no
position 0) for all donor sites and checked the presence of a
GYNGYN pattern. In agreement with the donor consensus
sequence that shows no GY dinucleotide 3 nucleotides up- or
downstream of the donor site, we found only 8,550 (5.2%)
tandem donors from the total of 165,295 annotated donor
sites (Table 1). Divided into the four different GYNGYN pat-
terns, GTNGTNs and GCNGTNs are the most frequent ones
while GCNGCN is very rare. Consistent with the proposed
nomenclature for NAGNAG acceptors, we termed the
upstream donor that renders the complete GYNGYN motif to
be intronic the 'i donor'. Likewise, the other donor is called
the 'e donor' because the upstream GYN becomes exonic
using this donor (Figure 1a). Note that, inversely to NAGNAG
acceptors, the 'e donor' is located downstream of the 'i donor'.
We use lower case letters to denote the two donor sites and
upper case letters for the two acceptor sites to distinguish
between the transcripts that arise by alternative splicing at
tandem donors or acceptors and between combinations of
alternative donor and acceptor usage (Figure 1b; see also
Discussion).
By searching dbEST and the human mRNAs from GenBank,
we identified experimental evidence for alternative splicing at
110 (1.3% of 8,550) tandem donors (in the following we term
these tandem donors 'confirmed') (Table 1; Additional data
file 1). We term the remaining 8,440 donors 'unconfirmed'
with the notion that they are enriched in GYNGYN donors
that are not functional. The percentage of confirmed tandem
d o n o r s  i s  c o n s i d e r a b l y  h i g h e r  f o r  G T N G T N  ( 2 % )  a n d
GTNGCN (1.6%) patterns. No confirmed GCNGCN donor was
found, presumably because this motif is very rare and because
the weaker GC donor requires a more stringent sequence con-
text. Since ESTs are random high-throughput samples from
the transcriptome, spurious or mis-spliced entries may pol-
lute dbEST, especially if the EST number for a particular locushttp://genomebiology.com/2006/7/7/R65 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. R65.3
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is high [21,22]. However, the likelihood of splicing errors
decreases if the respective splice event is represented by more
than one EST and/or if the EST ratio between alternative
splice forms is not extreme. From the 110 confirmed tandems,
50 (45%) have at least two ESTs and 19 (17%) have at least five
ESTs for e as well as i transcripts. Likewise, in 85 cases (77%)
the minor splice form is confirmed by more than 1% of the
ESTs that are spliced at the tandem donor, and in 49 cases
(45%) this fraction is at least 5%. Thus, although we cannot
exclude that some confirmations of GYNGYN tandem donors
represent rare errors of the splice machinery, the majority
seems to comprise real alternative splice events.
A or G is strongly preferred at intron position +3 for standard
donor sites GTN, while T and C have lower frequencies [23].
We classified the confirmed GTNGTN donors according to
their pattern into three groups: GTRGTR (R = A or G); GTT-
GTR, GTRGTT or GTTGTT; and GTCGTN or GTNGTC. The
GTRGTR pattern is clearly preferred as 86% (70 of 81) of the
confirmed GTNGTN donors belong to this group. A smaller
fraction has one or two T at the N-positions (8 of 81, 10%) and
the third group is very rare, with only three cases. These find-
ings indicate that the common splicing machinery is operat-
ing at these sites. For GTNGCN and GCNGTN donors, we
found very similar results: 21 of 29 (72%) have R at both N-
positions and two (7%) one T. In addition, we found the
exceptional pattern GTAGCC six times (21%).
Furthermore, we generated a sequence logo for the genomic
context of confirmed tandems, unconfirmed GYNGYNs
where either the e or i donor is confirmed, and donor sites
without a GYNGYN motif (Figure 2). The three nucleotides
up- and downstream of confirmed tandem donors are non-
randomly distributed (Figure 2b), consistent with the obser-
vation that both donor sites are alternatively used in the
splice process. In contrast, either the upstream or down-
stream side of unconfirmed GYNGYNs is more randomly dis-
tributed. The higher conservation of the AG upstream of the
unconfirmed GTNGTN and GTNGCN motifs with annotated
i donor (Figure 2c) indicates that the non-consensus intronic
sequence (compare Figure 2a) is compensated by a more
stringent match to the exonic part of the donor consensus
sequence.
In some cases it has been reported that single nucleotide pol-
ymorphisms (SNPs) in the vicinity of donor sites lead to a
shift in the splice site [24-26]. To check if there is a general
trend that confirmed GYNGYNs might be influenced by SNPs
in their genomic flanks, thus giving rise to allele-specific
splice forms [27], we selected all SNPs from dbSNP that are
mapped to the 100 nucleotide context up- and downstream of
these tandem donors. We found that 64 (58%) of the
confirmed GYNGYNs do not have an annotated SNP in this
206 nucleotide region. As a control we randomly selected 500
unconfirmed GYNGYNs and found that 56% (279 of 500) do
Table 1
Human tandem donor sites divided into the four different GYNGYN patterns
Splice donor pattern Number and % of tandem donors* Number and % of confirmed donors
GTNGTN 4,152 2.51% 81 1.95%
GTNGCN 856 0.52% 14 1.64%
GCNGTN 3,510 2.12% 15 0.43%
GCNGCN 32 0.02% 0 0.00%
GYNGYN 8,550 5.17% 110 1.29%
*Percent of all 165,295 annotated donor sites
Nomenclature for tandem donor sites and transcripts Figure 1
Nomenclature for tandem donor sites and transcripts. (a) Splicing at the 
downstream e donor makes the upstream GYN exonic while splicing at 
the upstream i donor makes the complete GYNGYN motif intronic. (b) 
Simultaneous usage of e or i donor and E or I acceptor results in four 
different transcripts (e-E, i-E, e-I, and i-I).
GYN
ie
Donor
GYN
e
Transcript
i
(a)
(b)
GYN
GYN
Donor
ie
NAG
Acceptor
I E
e−E GYN
NAG GYN i−I
NAG e−I
GYN i−E
GYN
NAG
Transcript
GYN
GYN
GYN
GYN
NAG
NAG
NAG
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not have a SNP in this 206 nucleotide region. Thus, we con-
clude that most of the confirmed tandems are not associated
with allele-specific splice forms.
Experimental verification of alternative GYNGYN 
splicing
To further support the EST-derived confirmation of alterna-
tive splice events at tandem donor sites, we performed RT-
PCR in several human tissues. We selected eight genes with
confirmed GYNGYNs having at least three ESTs for e and i
transcripts (Table 2, Figure 3a). We directly sequenced the
RT-PCR products and inspected the sequencing traces for
overlapping trace signals after the exon-exon junctions (Fig-
ure 3, e+i). This approach is based on control experiments
showing that minor splice forms with a frequency down to
10% of the total transcripts can be clearly detected by direct
sequencing (Additional data file 5). For seven of these eight
GYNGYNs, we found e and i transcripts in all tissues where
expression of the respective gene was observed. We detected
no variation among the tissues, suggesting that these seven
tandem donors are not regulated in a tissue-specific manner.
Next, we analyzed the splicing at the tandem donor of STAT3
in leucocytes of six individuals and consistently observed
both transcripts. This agrees with our in silico finding that
tandem donor splicing in general does not depend on specific
genotypes and further excludes the possibility that a peculiar-
ity of the spliceosome or its components is the reason for the
two splice forms.
Differences in U1 snRNA binding for confirmed and 
unconfirmed GYNGYN donors
The U1 snRNA determines the donor site by base pairing with
the mRNA [20]. To define the strength of a donor site, we cal-
culated: the average free energy of U1 snRNA binding; the
average number of base pairs between donor sites and U1
snRNA [28]; and the maximum entropy scores [29]. In gen-
eral, the e donor of confirmed GTNGTNs has a higher
strength compared to the i donor (Additional data file 2). In
agreement with that, the e donor is annotated in 73% (59 of
81) of the confirmed GTNGTN donors in RefSeq. Further-
more, the e donor is represented by an average of 233 ESTs,
which is about tenfold higher than the average of 24 ESTs for
the i donor. These findings can be explained with a stronger
consensus sequence downstream of a standard GT donor
compared to the three upstream positions (Figure 2a). For
G T N G C N  a n d  G C N G T N  t a n d e m s ,  w e  h a v e  t o  d i s t i n g u i s h
between the GT and GC donor site since GT is stronger than
GC (Additional data file 2). Consistently, of the 29 confirmed
GTNGCN and GCNGTN tandems, the GT donor is annotated
in 23 cases (79%) in RefSeq and the splicing at the GT donor
is represented by an average of 116 ESTs compared to the
average of four ESTs for GC donors.
Nevertheless, there are 17 of the 81 confirmed GTNGTN tan-
dems with more ESTs for the i donor than the e donor. There-
fore, we compared the free energy values and found that 15 of
these 17 cases (88%) have a lower free energy for the i donor,
Sequence logos of the 12 nucleotide donor context (3 nucleotides upstream to 6 nucleotides downstream of the GYN) Figure 2
Sequence logos of the 12 nucleotide donor context (3 nucleotides upstream to 6 nucleotides downstream of the GYN). (a) Donors without a GYNGYN 
motif; (b) and the logo of the 12 nucleotide context (3 nucleotides upstream to 3 nucleotides downstream of the GYNGYN pattern) for GTNGTN, 
GTNGCN and GCNGTN donors classified into confirmed; (c) unconfirmed with annotated i donor; (d) unconfirmed with annotated e donor. Note that 
unconfirmed GTNGCNs with annotated e donor comprise only ten cases and unconfirmed GCNGTNs with annotated i donor only six cases. Sequence 
logos were generated with WebLogo [69].
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Alternative splicing at the tandem donor of exon 21 of (a) human STAT3 and (b) mouse Stat3 Figure 3
Alternative splicing at the tandem donor of exon 21 of (a) human STAT3 and (b) mouse Stat3. Electropherograms are shown for direct sequencing of RT-
PCR amplicons (e+i) and sequencing of isolated clones representing e and i transcripts (e and i, respectively). The cursor is positioned on the nucleotide 
upstream of the conserved GTAGTT motif. Numbers and ratios of clones representing e and i transcripts are given for human and mouse kidney (e:i).
Table 2
Experimental verification of human GYNGYN donors
Gene symbol RefSeq ID Upstream exon Annotated donor Pattern Transcripts found*
ANAPC4 NM_013367 18 i GTAGTA e < i
ANGPT1 NM_001146 4 e GTGGTA e > i
SEMA5B NM_001031702† 16 e GTGGTG e > i
RBM10 NM_005676† 10 e GTGGTG e < i
TOM1 NM_005488 14 i GTAGTA e < i
STAT3 NM_003150† 21 i GTAGTT e > i
CXorf44 NM_138362 2 e GTAGCA e < i
LTBP1 NM_206943 14 e GTAGCC e
*e < i means higher expression of i transcripts; e > i means higher expression of e transcripts; e means only e transcripts found. All sequence traces 
are deposited in the NCBI Trace Archive (Additional data file 4). †The alternative donor is annotated in another RefSeq transcript.
(a)
e+i
e
i
e:i
(b)
139:24 (85.3% e) 178:37 (82.8% e)R65.6 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. http://genomebiology.com/2006/7/7/R65
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Figure 4 (see legend on next page)
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thus allowing a more stable U1 binding (Figure 4a). Likewise,
56 of the remaining 64 confirmed GTNGTNs (88%) with
more ESTs for the e donor have a lower free energy for the e
donor. For GTNGCN and GCNGTN tandems, we found very
similar results as in 90% (26 of 29) the donor with the lower
free energy is represented by more ESTs. In agreement with
other experimental and computational studies [30-32], the
free energy of the U1 snRNA binding generally determines the
donor that is used more frequently.
Since only a small fraction of all human tandem donors are
confirmed, we searched for differences between confirmed
and unconfirmed ones. Plotting the free energy values for e
and i donors shows that most confirmed GTNGTNs are
located at the left part (Figure 4a) while unconfirmed
GTNGTNs can be separated by having a low free energy for
either the e or the i donor (Figure 4b). Comparing the average
free energies, we found that the e as well as the i donor of con-
firmed GYNGYNs is significantly stronger than the respective
unannotated donor of unconfirmed GYNGYNs (Table 3, t-
test, P-value < 0.00001). In contrast, the annotated donor of
unconfirmed GYNGYNs is significantly stronger than the
respective donor of confirmed GYNGYNs (Table 3, t-test, P-
value < 0.00001). We repeated this analysis using the average
number of base pairs and the maximum entropy scores to
measure the strength of donor sites and found the same
results (Table 3, t-test, all P-values < 0.00001). Dividing the
confirmed tandem donors into GTNGTNs, GTNGCNs and
GCNGTNs also leads to consistent results (Additional data
file 2). Thus, unconfirmed tandem donors are characterized
by a strong donor that successfully competes for U1 snRNA
binding with the much weaker donor. The smaller difference
between both donors for confirmed tandems probably allows
U1 binding to both sites, leading to the observed splice
variants.
We assumed that the strength of both donors might be a cri-
terion to distinguish functional from non-functional tandem
donors. To test this experimentally, we selected nine uncon-
firmed GTNGTNs with a low free energy for both donor sites
for experimental verification. As for confirmed GTNGTNs,
RT-PCR products were directly sequenced and the sequenc-
ing traces were inspected for overlapping sequences. For
none of the nine candidates, we found evidence for alternative
splicing at the tandem donor, suggesting that the majority of
unconfirmed GTNGTNs is presumably not alternatively
spliced. However, our direct sequencing approach does not
exclude that the alternative transcript is expressed at a low
frequency.
We conclude that: stable U1 binding is necessary but not suf-
ficient for alternative tandem donor splicing; the currently
confirmed GYNGYN represent a large fraction of all func-
tional tandem donors; and, in contrast to NAGNAG acceptors
[14], alternatively spliced GYNGYNs are not easily
predictable.
Confirmed tandem donors have over-represented 
motifs in their intron flanks
Since the free energy of U1 binding seems not to be the only
discriminative criterion, we searched for other differences
between confirmed and unconfirmed GTNGTNs. The regula-
tion of alternative splicing often involves auxiliary exonic and
intronic splice enhancer and silencer elements (abbreviated
ESE, ESS, ISE, and ISS, respectively) that are bound by trans-
acting RNA-binding proteins like serine/arginine rich (SR)
The free energy values in kcal/mol for e and i donor of human (a) confirmed GTNGTNs and (b) unconfirmed GTNGTNs Figure 4 (see previous page)
The free energy values in kcal/mol for e and i donor of human (a) confirmed GTNGTNs and (b) unconfirmed GTNGTNs. In (a) black triangles represent 
tandem donors with more ESTs for the e donor, and blue crosses tandem donors with more ESTs for the i donor. In (b) black triangles represent 
annotated e donors, and blue crosses annotated i donors. To better illustrate the distribution of the free energies, we added a random number between -
0.1 and 0.1 to each value (necessary since many donor sites have the same 9 nucleotide context pattern).
Table 3
Characteristics of U1 snRNA binding to human confirmed and unconfirmed GYNGYN donors
Average
Free energy (kcal/mol)* Number of base pairs* Maximum entropy score†
ieieie
Unconfirmed, e 
annotated
-1.92 -5.46 3.12 6.69 -18.13 7.95
Unconfirmed, i 
annotated
-5.01 -0.24 6.49 3.30 4.63 -16.02
Confirmed -3.68 -4.25 4.84 6.09 -5.88 1.65
*Computed with the Splice-site Analyzer tool [67]. †Computed with MaxEntScan [68].R65.8 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. http://genomebiology.com/2006/7/7/R65
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proteins and hnRNPs [33-36]. Previous computational stud-
ies followed by experimental verification identified 238 hex-
amers as ESEs [37], 2,060 octamers as ESEs and 1,019
octamers as ESSs [38], and 133 hexamers as ISE motifs in the
vicinity of donor sites [39]. We used these motifs to compare
their average frequency between both groups. The 100 nucle-
otide exonic flanks of confirmed GTNGTNs are indistinguish-
able from unconfirmed ones when comparing the frequency
of the 238 ESE hexamers (average of 10 ESEs per exon flank
for both groups) and have a slight but not significantly higher
frequency of ESE octamers (average 7.2 versus 6.5). The ESS
frequency is slightly, but not significantly, lower for exon
flanks of confirmed tandem donors (average 1.3 versus 2).
However, we found a significantly higher frequency of ISE
motifs in the 100 nucleotide intron flanks for confirmed
GTNGTNs (average 10 versus 8, t-test: P = 0.0174). We
repeated this analysis using a shorter exonic/intronic context
(50 nt) and found consistent results (data not shown).
To find out if specific ISE hexamers are statistically over-rep-
resented, we used a resampling strategy. We randomly sam-
pled 10,000 sets, each comprising 81 intron flanks from
unconfirmed GTNGTNs. We estimated the P-value as the
fraction of random sets with a higher frequency of a given ISE
hexamer compared to the observed frequency in confirmed
tandem donors. CGGGGT is the only one among the 133ISE
motifs that is significantly over-represented in the vicinity of
confirmed GTNGTN donors as all 10,000 random sets have a
lower frequency (P < 1/10,000 × 133 = 0.0133 to correct for
multiple testing). To find out if other sequence motifs are
over-represented in the intron flanks of confirmed tandem
donors, we repeated this procedure with tetramers. A word
length of 4 nucleotides was chosen to account for the rather
small data set. We only compared the 119 tetramers that occur
at least with the expected frequency in the intron flanks of
confirmed GTNGTNs. We found a significant overrepresenta-
tion for GGGT and CGGG (both have a higher frequency in
only two random sets, P < 3/10,000 × 119 = 0.0357), while
the tetramer GGGG has a corrected P-value slightly above the
0.05 threshold (higher frequency in five random sets, P <
0.0714). Since both GGGT and CGGG are substrings of the
over-represented ISE CGGGGT, no new sequence motifs were
found. The common feature of the over-represented sequence
motifs is the G triplet. Interestingly, this motif occurs in 82 of
the 133 ISEs [39] and is a known splice enhancer [40]. Since
both splice sites of confirmed GTNGTNs are weaker com-
pared to the annotated splice site of unconfirmed ones (Table
3), the G triplets might simply be associated with weak
GTNGTNs. To exclude this possibility, we compared the aver-
age GGG frequency with unconfirmed GTNGTNs having a
low U1 binding potential for both e and i donor (average free
energy -3 kcal/mol for the e donor, -2.2 for the i donor) and
still found an over-representation in the intron flanks of con-
firmed GTNGTNs (average 4.4 versus 2.6 G triplets per intron
flank). Since this triplet was found to be more frequent in
shorter introns [41], we divided our confirmed and uncon-
firmed datasets into short and long introns using 200 nucle-
otide as a cut-off. Consistently, the GGG is more frequent in
the flanks of short as well as long introns with confirmed
GTNGTNs (average 8.3 versus 4.4 G triplets per short intron,
average 3.4 vs 2.7 per long intron). We also observed a notice-
able higher ISE hexamer frequency in the intronic flanks of
confirmed GTNGCN and GCNGTN tandems (average 12.7
versus 10.8, not significant), but only a slightly higher
frequency of ESE hexamers and octamers in their exon flanks
(data not shown). Specifically, G triplets are also more fre-
quent in the intronic flanks of confirmed GTNGCN and
GCNGTN donors compared to unconfirmed ones (average 5
versus 4.1). Thus, the occurrence of G triplets is another dis-
criminating criterion between confirmed and unconfirmed
tandem donors.
Protein impact of alternative splicing at GYNGYN 
donors
Of the 81 confirmed GTNGTNs, 72 (89%) are located down-
stream of a coding exon; thus, alternative splicing at these
sites results in 3 nucleotide indels into the coding sequence.
The effect for the protein depends on the phase of the intron
as well as the sequence of the GTNGTN and the upstream/
downstream exon. In intron phase 0 (intron location between
two codons) the GTN of the i donor is inserted/deleted and
codes for a valine. In intron phase 1 and 2 (location between
the first and second codon position, respectively), three dif-
ferent events are possible: indel of a single amino acid;
exchange of a dipeptide and a different amino acid; and indel
of a stop codon. Of the 72 GTNGTNs, 37 (51%) are located in
phase 0, thus a valine indel is the most frequent event at the
protein level. Of the 28 (39%) GTNGTNs in phase 1, 18 result
in single amino acid events (14 times glycine, 2 times
arginine, 2 times serine), 8 exchange a dipeptide and an unre-
lated amino acid and in two cases splicing at the i donor cre-
ates a stop codon. The 7 (10%) confirmed GTNGTNs in phase
2 are interesting since they either result in indels of rare
amino acids (three times tryptophan, one cysteine, one tyro-
sine) or insert/delete a stop codon in two cases.
Thus, alternative splicing at four tandem donors has a more
drastic impact on the proteins by the indel of a stop codon
(phase 1: FAM65A, NM_024519, exon 21; BRSK2,
NM_003957, exon 19; phase 2: ABC1, NM_022070, exon 8;
KLHL5, NM_001007075, exon 3). In two cases (KLHL5,
ABC1) the splice form with the premature stop codon is a
clear candidate for nonsense-mediated mRNA decay [42],
which potentially results in a down-regulation of the protein
level. For the other two cases, the tandem donor affects the
last intron of the transcript, thus the stop codon-containing
splice variant should be translated into a protein with a
shortened carboxyl terminus (FAM65A 33 residue deletion at
the carboxyl terminus, BRSK2 7 residue deletion).
The protein impact of the 28 GTNGCN and GCNGTN tan-
dems that are located within the CDS comprise 22 singlehttp://genomebiology.com/2006/7/7/R65 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. R65.9
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amino acid indels (intron phase 0: alanine, valine; phase 1:
arginine, glycine, serine; phase 2: arginine, glutamine, leu-
cine) and 6 dipeptide exchanges (all in phase 1). Compared to
the protein events for GTNGTNs, the indel of alanine,
glutamine and leucine is only observed for tandems with a GC
donor.
Next, we compared the frequency of single amino acid events
in phase 1 and 2 for confirmed and as a control for uncon-
f i r m e d  G T N G T N s .  W h i l e  o n l y  4 2 %  ( 4 9 5  o f  1 , 1 8 0 )  u n c o n -
firmed tandem donors in phase 1 result in a single residue
indel, this percentage is significantly higher for confirmed
tandems (64%, 18 of 28, Fisher's exact test: P = 0.02). The
small number of phase 2 tandems does not allow a significant
result, although the same trend is visible (100%, 5 of 5 con-
firmed tandems; 76%, 431 of 566 unconfirmed tandems;
leaving stop codon events out). These findings argue for a
preference to insert/delete only single amino acids, presuma-
bly because this is a less dramatic event compared to dipep-
tide exchanges. However, we cannot exclude the possibility
that this result is an indirect consequence of a sequence bias
of the GTNGTN motif and its context for confirmed tandems
that primarily aims at a more stable U1 snRNA binding. For
GTNGCN and GCNGTN tandems, only phase 2 donors result
in a high percentage of single amino acid indels (100%, 5 of 5
confirmed; 81%, 781 of 962 unconfirmed) while phase 1
events show no bias (40%, 4 of 10 confirmed; 48%, 524 of
1103 unconfirmed).
Tandem donors in seven other species
Further, we asked whether alternative splicing at GYNGYN
donors is limited to humans or a general phenomenon.
Therefore, we extended our analysis to the RefSeq transcripts
of mouse (Mus musculus), rat (Rattus norvegicus), chicken
(Gallus gallus), zebrafish (Danio rerio), fruitfly (Drosophila
melanogaster), and nematode (Caenorhabditis elegans).
The percentage of GTNGTN motifs in all donor sites is quite
similar in all species and ranges between 2.1% and 3.4%
(Table 4). For mouse, rat, zebrafish, fruitfly, and nematode,
evidence for alternative splicing is found for 0.8% to 1.5% of
all GTNGTN donors (Additional data file 3). The minor splice
form is represented by at least 5% of the ESTs that are spliced
at the tandem donor for most confirmed GTNGTNs (47% for
mouse, 83% for rat, 60% for zebrafish, 90% for fruitfly, 92%
for nematode), making splicing errors unlikely. Furthermore,
53% (26 of 49) of the mouse tandem donors have at least two
ESTs for both splice forms, while this percentage drops for
the other species due to the lower EST number (25% for rat,
60% for zebrafish, 42% for fruitfly, 31% for nematode). For
chicken, we found only one confirmed tandem donor (0.2% of
all GTNGTNs). Whether this lower percentage points at an
exception for chicken is difficult to assess and deserves fur-
ther research as the number of RefSeq transcripts and ESTs is
rather limited. Next, we searched for GTNGCN and GCNGTN
donors in those six species and, as for GTNGTNs, we found a
comparable percentage of tandem donors and confirmed
ones in all species (Table 4, Additional data file 3). Finally, we
searched tandem donors in the plant Arabidopsis thaliana
using the CDS annotation from GenBank and detected 36
confirmed GTNGTNs and 8 confirmed GCNGTNs/GTNGCNs
(Table 4, Additional data file 3). Thus, all investigated species
are able to produce e and i transcripts at tandem donors by
alternative splicing and this phenomenon is not restricted to
humans.
As in humans, the preferred motif for confirmed GTNGTNs is
GTRGTR in all species except for C. elegans and A. thaliana
where a higher fraction of GTNGTNs has one or two Ts at the
N-positions (Table 5). The corresponding nucleotide in U1
snRNAs is a T that is post-transcriptionally modified to a
Table 4
GTNGTN, GTNGCN and GCNGTN donors in eight investigated species
Species Number of donors* GTNGTN GTNGCN and GCNGTN
Observed Confirmed Observed Confirmed
H. sapiens 165,295 4,152 2.51%† 81 1.95%‡ 4,398 2.66%§ 29 0.66%¶
M. musculus 125,332 3,188 2.54% 49 1.54% 3,237 2.58% 12 0.37%
R. norvegicus 53,631 1,424 2.66% 12 0.84% 1,440 2.69% 3 0.21%
G. gallus 19,793 554 2.80% 1 0.18% 553 2.79% 2 0.36%
D. rerio 29,091 619 2.13% 5 0.81% 699 2.40% 1 0.14%
D. melanogaster 40,811 1,274 3.12% 19 1.49% 1,906 4.67% 5 0.26%
C. elegans 92,938 3,195 3.44% 26 0.81% 2,838 3.05% 1 0.04%
A. thaliana 112,684 3,541 3.14% 36 1.02% 2,091 1.86% 8 0.38%
*Total number of all unique donor sites annotated in RefSeq transcripts; for A. thaliana total number of unique donor sites based on the CDS feature 
annotation of GenBank. †Number of observed GTNGTNs/number of all donors. ‡Number of confirmed GTNGTNs/number of observed 
GTNGTNs. §Number of observed GTNGCNs and GCNGTNs/number of all donors. ¶Number of confirmed GTNGCNs and GCNGTNs/number 
of observed GTNGCNs and GCNGTNs.R65.10 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. http://genomebiology.com/2006/7/7/R65
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pseudouridine (ψ), thus allowing base pairings with A or G
[43,44]. We could not find an U1 snRNA gene with a different
nucleotide at this position in the C. elegans or A. thaliana
genome. Thus, except for the possibility of non-canonical ψ-T
base pairings that have been observed at position +3 [30], we
currently have no other explanation for the higher percentage
of GTT tandem donors in these two species.
Conservation of exonic and intronic flanks in mouse
Having observed several alternative GTNGTN splice events in
human and mouse, we found conservation of the GTNGTN
motif for 53 (65.4%) of the 81 human confirmed GTNGTNs.
To assess whether this percentage is high or not, we counted
GTNGTN conservation for the 3,909 unconfirmed tandems
(162 of the 4,071 have no orthologous locus in mouse) and
found a very similar percentage of 65.5% (2,561 of 3,909). The
fraction of tandem donors that have a completely identical
GTNGTN pattern in mouse is also equal: 40 of 81 (49.4%)
confirmed, 1,939 of 3,909 (49.6%) unconfirmed. Thus, there
is no evidence for a general selection pressure to maintain
confirmed tandem donors since the divergence of the human-
mouse ancestor.
However, a considerable fraction (10 of 53 (19%)) of the con-
served and confirmed human GTNGTNs is also confirmed in
m o u s e .  F o r  e x a m p l e ,  t h e  G T A G T T  d o n o r  o f  i n t r o n  2 1  o f
STAT3 is conserved in mouse and both e and i transcripts are
supported by mouse ESTs. As in humans, we performed RT-
PCR in several mouse tissues to further support the EST-
derived confirmation of alternative splice events (Figure 3b).
We found experimental evidence for alternative splicing at
the  Stat3  tandem donor in all investigated tissues and
observed a strikingly similar trace pattern in human and
mouse (Figure 3, e+i). Accordingly, the ratio of e and i tran-
scripts estimated by the EST/mRNA counts are virtually
identical (e transcripts 57 of 74 (77%)) human ESTs vs 55 of
69 (79.7%) mouse ESTs). To accurately quantify the ratio of e
and i transcripts in one selected tissue, we subcloned the RT-
PCR product, sequenced individual clones and found a
remarkable agreement in the transcript ratio: 82.8% of the
human clones indicate splicing at the e donor, which is almost
equal to 85.3% in the mouse (Figure 3, e:i). Interestingly, this
tandem donor is conserved in several other mammals and the
e:i ratio is very similar (9:2 ESTs for rat, 12:3 ESTs for cow,
9:1 ESTs for dog). This indicates that, in addition to the tan-
dem donor, regulatory elements may be conserved.
The intronic flanks of alternative exons are significantly more
conserved in mouse compared to the flanks of constitutive
exons, a fact which is presumably attributed to the force to
maintain regulatory elements [45]. From the human-mouse
genomic alignments, we calculated a per-position identity
value for the region 30 nucleotides up- and downstream of
the GTNGTNs. For a specific position, this value is the frac-
tion of identical nucleotides in all alignments [45,46]. We cal-
culated per-position identities for three groups: group 1,
confirmed human tandem donors with a conserved GTNGTN
motif in mouse; group 2, the subset of group 1 that is con-
firmed in human and mouse; and group 3, unconfirmed
human tandems. Plotting these average values, it can be seen
that group 1 and, in particular, group 2 have noticeably higher
identities for both the exonic and intronic side compared to
group 3 (Figure 5). The exonic identities for the 10 human and
mouse confirmed and conserved tandem motifs exceed 90%
for most positions, a feature that is also typical for alternative
exons [47]. Furthermore, the GTNGTN pattern with 3 nucle-
otides up- and downstream is completely identical between
both species for these 10 tandems and average identities of
more than 80% are observed for the first 13 intronic
positions.
Discussion
We report the occurrence of alternative splice donor usage for
GTNGTN, GTNGCN, and GCNGTN motifs in eight investi-
gated eukaryotic species. Apart from our experimental verifi-
cation of seven human and one mouse GYNGYN donors,
several lines of evidence indicate that the majority of
observed events is attributable to real alternative splicing.
Firstly, numerous GTNGTNs are confirmed by multiple
Table 5
Number of confirmed GTNGTN donors divided into three groups according to their motif
GTRGTR GTRGTT + GTTGTR + GTTGTT GTCGTN + GTNGTC
H. sapiens 70 86% 8 10% 3 4%
M. musculus 44 90% 4 8% 1 2%
R. norvegicus 10 83% 2 17% 0 0%
G. gallus 00 % 1 * 1 0 0 % 00 %
D. rerio 5* 100% 0 0% 0 0%
D. melanogaster 14 74% 5 26% 0 0%
C. elegans 11 42% 15 58% 0 0%
A. thaliana 16 44.5% 16 44.5% 4 11%
*Case number too low to draw any conclusion.http://genomebiology.com/2006/7/7/R65 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. R65.11
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ESTs/mRNAs and for several of these events both e and i
transcripts are deposited in the RefSeq database. Secondly,
the existence of orthologous tandem donors that are con-
firmed in two or more species makes EST artifacts or data-
base errors unlikely. Thirdly, these GTNGTN donors have a
higher conservation of the exonic and intronic flanking
regions, a situation that is typical for conserved alternative
splice events [45,46,48,49]. Fourthly, all of the six investi-
gated human individuals express e and i transcripts for
STAT3, thus excluding the possibility of allele-specific instead
of alternative splicing [27]. Finally, by manual examination of
all human confirmed GYNGYNs, we excluded the existence of
paralogs or processed pseudogenes that could mimic alterna-
tive splicing at a tandem donor.
We found that the percentage of donor sites with a GYNGYN
motif as well as the percentage of tandem donors that are con-
firmed is very similar between the eight investigated species
(tolerating some variation probably due to differences in the
number of ESTs and mRNAs). Given the large evolutionary
distance between C. elegans, A. thaliana and humans, it is
likely that all species that have alternatively spliced genes are
able to produce e and i transcripts at certain tandem donor
sites. The detection of 44 alternatively spliced tandem donors
in A. thaliana is consistent with the finding that alternative
splicing in plants is not as rare as thought for a long time
[50,51]. Previously, we have found that alternative NAGNAG
splicing is widespread in human, mouse, and fruit fly but not
in  C. elegans [12]. To compare the numbers of GYNGYN
donors and NAGNAG acceptors, we extended and updated
our previous NAGNAG analyses [12,14] to the seven species
having a RefSeq annotation in the UCSC Genome Browser
(Table 6). In general, the percentage of confirmed NAGNAGs
is one order of magnitude higher compared to GYNGYN
donors. This can be explained by large differences in the
mechanisms of donor and acceptor site recognition. While
the acceptor AG is bound by U2AF35, the donor site is recog-
nized by base pairing with the U1 snRNA. In contrast to the
acceptor, the binding site of U1 comprises a larger range that
is visible by the non-random nucleotide distribution for the
last three exonic and first six intronic positions (Figure 2a).
This imposes more sequence constraints on a tandem donor
site and prevents the extensive use of potential e and i donors
compared to potential E and I acceptors. Apart from human
Per position identity values in human mouse alignments for the region 30 nucleotides up- and downstream of the GTNGTN motif Figure 5
Per position identity values in human mouse alignments for the region 30 nucleotides up- and downstream of the GTNGTN motif. The black line 
represents unconfirmed human GTNGTN donors, the blue line confirmed human tandem donors with a conserved GTNGTN motif in mouse, and the 
green line conserved GTNGTNs that are confirmed in human and mouse. To avoid large variations due to the low case numbers, we calculated for each 
position the average of this and the three positions up- and downstream.
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and mouse, the fruit fly has a relatively high percentage of
confirmed NAGNAG sites, which is probably due to the
higher percentage of tandem acceptors with the HAGHAG (H
= A, C, or T) pattern that preferably allow alternative splicing.
In contrast, a very low fraction of the NAGNAG acceptors of
C. elegans is confirmed, which is particularly striking since C.
elegans has the highest fraction of HAGHAG acceptors (Table
6). This rareness of alternative splice events at NAGNAG
acceptors is not due to differences in the EST coverage as C.
elegans  has the similar percentage of confirmed tandem
donors compared to the other species (Table 4). Therefore, it
should be attributed to the unusual properties of the 3' intron
ends of C. elegans that often lack consensus sequences for the
branch point and the polypyrimidine tract [52].
Although only a fraction of the tandem donors is confirmed,
we found features that distinguish confirmed from uncon-
firmed ones. Since the non-annotated donor of unconfirmed
tandems does not allow a sufficiently stable binding to the U1
snRNA, the other donor is used exclusively in the splice proc-
ess. For confirmed tandem donors, both sites allow a stable
binding to U1 snRNA. However, in most of the confirmed
cases one donor has a better strength and this results in its
preferred usage as measured by the EST ratio between both
transcripts. The second discriminative feature is the over-
abundance of G triplets in the intronic flanks of confirmed
GTNGTNs, especially for introns shorter than 200 nt. This
triplet is the core of many known ISE motifs [39,40] and was
demonstrated to function in splice site definition [41]. Inter-
estingly, in the human alpha-globin gene, GGG elements were
shown to exert their effect by binding to the nucleotides 8-10
(5'-CCT-3') of the U1 snRNA [40]. We have searched for over-
represented tetramers and found a significantly higher fre-
quency of CGGG and GGGT. Strikingly, the nucleotides 7-11
of U1 snRNA are 5'-ACCTG-3'. The CGGG as well as the GGGT
motifs are complementary to this part of U1; thus, it is
tempting to speculate that these motifs bind to U1 snRNA
with four instead of three base pairs. Since CGGG and GGGT
are more frequent in the intronic flanks of confirmed tandem
donors, they may be involved in alternative splicing at these
donor sites. If U1 snRNA is a critical factor, we do not expect
much variation in splicing between tissues since U1 is ubiqui-
t o u s l y  e x p r e s s e d  i n  h i g h  a m o u n t s .  C o n s i s t e n t  w i t h  t h i s
notion, the seven experimentally investigated tandem donors
exhibit similar e:i transcript ratios in all tissues.
Most confirmed GYNGYNs have a low free energy of U1
snRNA binding to both the e and i donor, suggesting that the
U1 snRNA can stably bind to both sites. However, there are a
few exceptions where one donor is much stronger than the
other one in a confirmed tandem (Figure 4a). The mechanism
of splicing at these sites remains unclear but there are several
hypotheses that might guide future investigations. For exam-
ple, it has been reported that U6 snRNA rather than U1
snRNA determines a donor site in the human FGFR1 gene
[53]. Moreover, there is evidence that splicing can occur with-
out U1 snRNA binding to the donor site [54,55]. Furthermore,
other protein factors can influence the splice site choice and/
or (de)stabilize U1 snRNA binding [56,57]. We believe that a
further experimental investigation of confirmed tandem
splice donors may help to elucidate further details of the
splicing process.
Previously, we found that the impact of SNPs in NAGNAG
acceptors on alternative splicing can be accurately predicted
[14]. Therefore, it would be interesting to check if similar
statements are possible for SNPs in GYNGYN donors. In prin-
ciple, a SNP in close proximity to an unconfirmed GYNGYN
donor might increase the base pairing capability to the U1
snRNA for the alternative donor, thus enabling alternative
splicing. SNPs that affect a confirmed tandem donor might
weaken U1 binding for one donor and result in the exclusive
usage of the other. During the SNP mapping, we found two
SNPs in the GTNGTN motif of human confirmed tandem
donors. For exon 4 of FAM3B (NM_206964), the verified
SNP rs417708 results in two alleles, GTGGTA and GCGGTA.
For the C allele, the free energy of the i and e donor is -3.4 and
-6.2 kcal/mol, respectively, while this value is more balanced
Table 6
NAGNAG acceptors for seven species
Species Number of 
acceptors*
NAGNAG acceptor HAGHAG acceptor Confirmed NAGNAG acceptor Confirmed HAGHAG acceptor
H. sapiens 164,841 9,465 5.7%† 3,530 37.3%‡ 1,511 16%§ 1,373 90.9%¶
M. musculus 125,233 7,116 5.7% 2,662 37.4% 1,087 15.3% 1,022 94.0%
R. norvegicus 53,598 3,080 5.7% 1,098 35.6% 215 7.0% 202 94.0%
G. gallus 19,794 1,069 5.4% 401 37.5% 97 9.1% 92 94.8%
D. rerio 29,067 1,540 5.3% 484 31.4% 132 8.6% 118 89.4%
D. melanogaster 39,441 1,584 4.0% 859 54.2% 177 11.2% 170 96.0%
C. elegans 92,867 4,184 4.5% 2,637 63.0% 33 0.8% 33 100.0%
H stands for A, C, or T. *Total number of all unique acceptor sites annotated in RefSeq transcripts. †Number of NAGNAG acceptors/number of all 
acceptors. ‡Number of HAGHAG acceptors/number of NAGNAG acceptors. §number of confirmed NAGNAG acceptors/number of NAGNAG 
acceptors. ¶Number of confirmed HAGHAG acceptors/number of confirmed NAGNAG acceptors.http://genomebiology.com/2006/7/7/R65 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. R65.13
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for the T allele (-5.3 for i and -5.9 kcal/mol for the e donor).
This agrees well with the prediction of the splice site analysis
server [58,59]. Thus, it is likely that only the T allele produces
two splice forms. The second SNP (rs11672749) is especially
interesting, since it affects the tandem donor of exon 5 of the
maternally imprinted PEG3  gene (NM_006210, GTGGTG
and GTGGGG alleles). Both homozygous G genotypes and
heterozygous genotypes with a maternally inactivated T allele
will result in an exclusive splicing at the i donor.
Higher eukaryotes typically express multiple transcripts and
proteins from a single gene. A prominent mechanism is alter-
native splicing as about 74% of the human multi-exon genes
express more than one splice variant [4]. Protein isoforms
can also be expressed from paralogous genes. Large gene fam-
ilies are observed to have a reduced frequency of alternative
splicing, consistent with the idea that the variability of those
gene products comes from the divergence of the gene copies
[60]. While most research focused on large changes intro-
duced by alternative splicing, it is becoming clear that there is
a surprisingly high number of very similar protein isoforms.
There are several mechanisms to introduce subtle protein
changes. The most widespread type is alternative splicing at
NAGNAG acceptors [12,15]. Furthermore, very similar mutu-
ally exclusive exons can lead to similar but functionally differ-
ent proteins [61]. Here, we found that alternative splicing at
GYNGYN donor sites occurs in all eight investigated species.
Despite not as frequent as confirmed NAGNAG acceptors, the
diverse protein changes further contribute to the plasticity of
these proteomes. Confirmed tandem donors and acceptors
are able to insert 12 of the 20 different amino acids by single
amino acid events and the dipeptide exchanges are even more
diverse. Further flexibility comes from the simultaneous use
of a GYNGYN donor and a NAGNAG acceptor for one intron
(Figure 1b). Such an example is intron 9 of BRUNOL4
(NM_020180), for which we found 14 e-E, 3 i-E and 6 e-I
transcripts in dbEST that result in protein forms with a GPA,
AA, or GP peptide, respectively.
Despite many GYNGYN donors, we found only a minority
that allows alternative splicing. Nevertheless, among the
human confirmed and evolutionary conserved tandem
donors we found a significant fraction to be confirmed in
other species. Moreover, the splicing pattern of the STAT3
GTNGTN donor is strikingly equal in human and mouse. In
light of the discussion about functional versus non-functional
alternative splicing [21,62], this is a strong indication that
these alternative splicing events are not splicing noise. Con-
sistently, such subtle changes by alternative splicing may
result in functional differences for the two proteins. An
arginine insertion between two zinc fingers results in a
human glucocorticoid receptor isoform (NM_001018075,
exon 3, GTAGTG) with an activity reduced to 48% [63,64].
Interestingly, this tandem donor is also conserved and con-
firmed in mouse. A similar subtle 6 nucleotide shift at a
GTAAATGT donor of ALDH18A1 results in an isoform that is
insensitive to ornithine inhibition [65]. Furthermore, there
are at least four reported cases of functional differences by
alternative NAGNAG splicing [15-18]. Thus, subtle alterna-
tive splice events are interesting candidates for further
research, especially since several of them occur in known dis-
ease genes [14].
Materials and methods
Identification of GYNGYN donors and NAGNAG 
acceptors
We downloaded from the UCSC Genome Browser [66] the
Human genome assembly (hg17, May 2004) as well as RefSeq
annotation (refGene.txt.gz, November 2005). We discarded
transcripts with an erroneous open reading frame or ambigu-
ous characters in their sequence. If more than one entry with
the same RefSeq ID exists, we selected the transcript with the
highest number of exons. From the transcripts, we extracted
a list of unique genomic positions of donor sites. We checked
the presence of a GT/GC dinucleotide at the annotated donor
position and 3 nucleotides up- or downstream. We repeated
this procedure for the other six eukaryotes having a RefSeq
annotation in the UCSC Genome Browser. The respective
genome assemblies are mm6 (March 2005) for M. musculus,
rn3 (June 2003) for R. norvegicus, galGal2 (February 2004)
for G. gallus, danRer2 (June 2004) for D. rerio, dm2 (April
2004) for D. melanogaster, and ce2 (March 2004) for C. ele-
gans. For A. thaliana, we used the genome assembly (NCBI,
build 5.0) to build a list of donor sites according to the CDS
feature annotations in GenBank format and screened this list
for donor sites with a GYNGYN sequence pattern.
For checking if a GYNGYN donor is confirmed (at least one
EST/mRNA for the e as well as i transcript), we compiled two
search strings: 30 nucleotides from the upstream exon and 30
nucleotides from the downstream exon for the i transcript;
and 30 nucleotides from the upstream exon, the GYN of the i
donor and 30 nucleotides from the downstream exon for the
e transcript. Then, we used BLAST against all ESTs and
mRNAs for the respective species, allowing at most one mis-
match or one gap but demanding exact identity for the region
27-33 for i-transcripts and 27-36 for e-transcripts. The ESTs
were downloaded from the UCSC Genome Browser (est.fa.gz,
November 2005). mRNAs were downloaded from GenBank
at the same date as the ESTs. For acceptor sites with a NAG-
NAG pattern, we repeated the analysis using analogous pro-
cedures and the same data described above.
Conservation analysis in mouse
Human-mouse genomic alignments (hg17-mm6) were down-
loaded from the UCSC Genome Browser (vsMm6/axtNet,
March 2005). We used the genomic position of human and
mouse donor sites to select the respective alignment chain.
From the alignments, we determined whether a human
GTNGTN donor is conserved (there is also a GTNGTN motif
in mouse) or completely identical. For the per-position iden-R65.14 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. http://genomebiology.com/2006/7/7/R65
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tity computation, we considered the alignment part up to 100
positions upstream and downstream. For each position, we
counted how often there is identity between human and
mouse (Nid), and how often there is a mismatch or gap
(Nmm). The per-position identity value is Nid/(Nid+Nmm).
Alignment positions with an 'N' aligned to a nucleotide were
ignored.
To find tandem donors that are orthologous and confirmed in
human and mouse, we used BLAST with the human-con-
firmed search strings against the search strings of the mouse-
confirmed GTNGTNs. Furthermore, we used BLAST with the
human-confirmed search strings against the mouse ESTs and
mRNAs. Using the UCSC and Ensembl genome browser, we
manually checked each hit with an E-value of less than 1e-3
for being alternatively spliced in both species and for having
a true orthologous relationship.
Strength of a donor site
We extracted a 9 nucleotide genomic context (3 nucleotides
upstream to 3 nucleotides downstream of the GYN) for the e
and i donor of confirmed and unconfirmed GYNGYNs. The
free energy and number of base pairs with the U1 snRNA were
computed according to [28] with the Splice-site Analyzer tool
[67]. The score according to the maximum entropy model
[29] was computed using MaxEntScan [68].
Motif search
We extracted the genomic sequence 100 nucleotides
upstream (exonic) and 100 nucleotides downstream
(intronic) of GTNGTN donor motifs. To identify over-repre-
sented ISE hexamer motifs, we used a resampling procedure
to estimate the P-value for a higher frequency in the intronic
flanks of confirmed GTNGTNs. To this end we randomly sam-
pled 10,000 sets of 81 intronic flanks of unconfirmed
GTNGTNs and computed the frequency for each of the 133
ISE motifs in the 10,000 random sets. The P-value for one
ISE is the fraction of random sets with a higher frequency
compared to the observed frequency for confirmed
GTNGTNs. To correct for multiple testing, each P-value is
multiplied by 133. For the general search for over-repre-
sented motifs, we decided to use tetramers (word length 4 nt)
instead of hexamers since the dataset of the confirmed tan-
dems is rather small. Since we were searching for over-repre-
sented motifs in the intronic flanks of confirmed GTNGTNs,
we expected that such motifs occur at least with the expected
frequency under a null model and with a significant higher
frequency compared to the flanks of unconfirmed GTNGTNs.
There are 97 overlapping tetramers in a 100 nucleotide
sequence, thus we analyzed a total of 81 × 97 = 7,857 tetramer
occurrences. For complete random sequences, each tetramer
should occur 7857/256 = 30.7 times. Since intron sequences
are not random, we found a total of 119 tetramers that occur
30 times or more in the flanks of confirmed GTNGTNs. For
these 119 tetramers, we repeated the procedure described
above but multiplied the P-value by 119.
Experimental verification of alternative splicing at 
tandem donors
Eight genes with multiple EST evidence for alternative splic-
ing at a tandem donor were analyzed by RT-PCR in different
tissues by using cDNA from multiple tissue cDNA panels (BD
Clontech Germany, Heidelberg, Germany) as PCR templates.
Primers were designed for the exons flanking the tandem
donor with distances to these donors that allow reliable
amplification and sequencing. PCR was performed in a total
volume of 25 µl using ReadyToGo PCR beads (GE Healthcare
Europe, Munich, Germany) with 5 pmoles of each primer and
1 µl of cDNA. Cycling conditions were 94°C for 30 s followed
by 35 cycles with 94°C for 20 s, 57°C for 30 s and 72°C for 30
s, followed by a final extension at 72°C for 10 minutes. Ampli-
fied fragments were precipitated with ethanol and ammo-
nium acetate, washed with ethanol and sequenced using
DyeTerminator chemistry (Applied Biosystems, Foster city,
USA) and the respective PCR primers on a 3730 xl DNA Ana-
lyzer (Applied Biosystems). Genes and their primer
sequences were: TOM1  (AGTTTGACATGTTTGCGCTG,
GCAGCCTTAACACCAGAGGA);  STAT3  (GCCATCTTGAG-
CACTAAGCC, GGTTCAGCACCTTCACCATT);  ANAPC4
(AGATGCTGCAGGAATCGAAG,
CTGGCTTTTGCAAACACTGA); RBM10 (AGGCTGGATCAG-
CAGACACT, TCCCTCTTAGAACCCTTGGC);  ANGPT1
(ACAAGGAAGAGTTGGACACC, GGGATTTCCAAAAC-
CCATTT);  SEMA5B  (AGCACGTCCTGTGGCATC, GTC-
CTCGTCTCGGTCCTTCT);  CXorf44
(GAGGGCAGGACTATGGGAG, AAATACTTCTCCTTCAT-
AGCGGA); and LTBP1  (GGACCTGTATTTGTCAAGCCA,
TAATGCAGTGTCCTGCTCCA). In addition, Stat3 of M. mus-
culus was analyzed in the respective Clontech mouse tissue
panel by amplifying and sequencing the homologous region
with the oligonucleotides GCCATCCTAAGCACAAAGCC and
GGCTCAGCACCTTCACCGTT. All sequence traces have been
deposited in the NCBI Trace Archive (TIs human:
1166719658-1166720385; mouse; 1166879453-1166879628).
To estimate the relative amounts of e and i transcripts of
human and mouse STAT3, we cloned the respective ampli-
cons into pCR2.1-TOPO (Invitrogen, Karlsruhe, Germany)
and propagated the clones in Escherichia coli TOP10 cells.
Plasmids were isolated from several isolated clones and their
inserts were sequenced using universal M13 primers.
The same strategy was applied to a set of genes with uncon-
firmed tandem splice donors. Genes and their primers were:
A2ML1 (NM_144670, exon 17, ACTTTCCTCAGCCCCTCATT,
AGTGCAGAAACTCATCGCCT);  TMEM63C  (NM_020431,
exon 1, GTGCTGAGGACGCAAATCA, CATCTCCAAG-
GAAGTCTCCG); RNPC3 (NM_017619, exon 13, ACCGGGT-
GAACCAAACTGTA, AGCTGTTACGCACAGTTCCA);
GOLGA3  (NM_005895, exon 5, CACCCCCTATATGGT-
CAACG, CACGACTGCTTCAGGGTGT); ART5 (NM_053017,
exon 2, GCCCCTATACAGGCCTTCTC, ATTGCAACACCGT-
TCAATCA); KIAA1853 (NM_194286, exon 8, CCCTCAAGCT-
GTGAGAGCAG, TGGTGAAGGAGTTCCCTGAA);  K5Bhttp://genomebiology.com/2006/7/7/R65 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. R65.15
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(NM_173352, exon 5, ACAACAACCGCTACCTGGAC,
AATCTCCACATCCAGGGAAA);  SAMD4B  (NM_018028,
exon 15, AACAGCATGCCCAGTCAGA, CTCAGCAGAGATC-
CCTCGAC); and LOC221711  (NM_194299, exon 9, TTCA-
GATGTTGGATTCCTTCC, TTTTTCATCCGCTGGTTTTC).
Data availability
To facilitate further experimental and computational studies
o f  t a n d e m  s p l i c e  s i t e s ,  w e  r e c e n t l y  d e v e l o p e d  a  d a t a b a s e ,
TassDB [70], which provides large collections of GYNGYN
donors and NAGNAG acceptors of eight species.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is an Excel spread-
sheet containing data on all human confirmed GYNGYN
splice donor sites identified in this study. Additional data file
2 is an Excel spreadsheet providing data about the strength of
e and i human GYNGYN donors. Additional data file 3 is an
Excel spreadsheet listing all confirmed GYNGYN donors for
seven species. Additional data file 4 is an Excel spreadsheet
presenting information about selected sequence traces that
exemplify the experimental verification of GYNGYN donors.
Additional data file 5 is a Word file describing the control
experiments for detecting minor splice forms by direct
sequencing of RT-PCR products.
Additional data file 1 Data for all human confirmed GYNGYN splice donor sites identi- fied in this study Data for all human confirmed GYNGYN splice donor sites identi- fied in this study Click here for file Additional data file 2 Data on the strength of e and i human GYNGYN donors Data on the strength of e and i human GYNGYN donors Click here for file Additional data file 3 Confirmed GYNGYN donors for seven species Confirmed GYNGYN donors for seven species Click here for file Additional data file 4 Selected sequence traces that exemplify the experimental verifica- tion of GYNGYN donors Selected sequence traces that exemplify the experimental verifica- tion of GYNGYN donors Click here for file Additional data file 5 Control experiments for detecting minor splice forms by direct  sequencing of RT-PCR products Control experiments for detecting minor splice forms by direct  sequencing of RT-PCR products Click here for file
Acknowledgements
We thank Gene Yeo for providing the ISE hexamer list and Anke Busch for
critical reading of the manuscript. The skillful technical assistance of Beate
Szafranski and Ivonne Görlich is gratefully acknowledged. This work was
supported by grants from the German Ministry of Education and Research
to SS (01GS0426) and to MP (01GR0504, 0313652D) as well as from the
Deutsche Forschungsgemeinschaft (SFB604-02) to MP.
References
1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J,
Devon K, Dewar K, Doyle M, FitzHugh W, et al.: Initial sequencing
and analysis of the human genome.  Nature 2001, 409:860-921.
2. Maniatis T, Tasic B: Alternative pre-mRNA splicing and pro-
teome expansion in metazoans.  Nature 2002, 418:236-243.
3. Graveley BR: Alternative splicing: increasing diversity in the
proteomic world.  Trends Genet 2001, 17:100-107.
4. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour
CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD: Genome-
wide survey of human alternative pre-mRNA splicing with
exon junction microarrays.  Science 2003, 302:2141-2144.
5. Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D, Thanaraj
TA, Soreq H: Function of alternative splicing.  Gene 2005,
344:1-20.
6. Lewis BP, Green RE, Brenner SE: Evidence for the widespread
coupling of alternative splicing and nonsense-mediated
mRNA decay in humans.  P r o c  N a t l  A c a d  S c i  U S A  2003,
100:189-192.
7. Stamm S, Zhu J, Nakai K, Stoilov P, Stoss O, Zhang MQ: An alterna-
tive-exon database and its statistical analysis.  DNA Cell Biol
2000, 19:739-756.
8. Kriventseva EV, Koch I, Apweiler R, Vingron M, Bork P, Gelfand MS,
Sunyaev S: Increase of functional diversity by alternative
splicing.  Trends Genet 2003, 19:124-128.
9. Resch A, Xing Y, Modrek B, Gorlick M, Riley R, Lee C: Assessing the
impact of alternative splicing on domain interactions in the
human proteome.  J Proteome Res 2004, 3:76-83.
10. Xing Y, Xu Q, Lee C: Widespread production of novel soluble
protein isoforms by alternative splicing removal of trans-
membrane anchoring domains.  FEBS Lett 2003, 555:572-578.
11. Hiller M, Huse K, Platzer M, Backofen R: Creation and disruption
of protein features by alternative splicing - a novel mecha-
nism to modulate function.  Genome Biol 2005, 6:R58.
12. Hiller M, Huse K, Szafranski K, Jahn N, Hampe J, Schreiber S, Backofen
R, Platzer M: Widespread occurrence of alternative splicing at
NAGNAG acceptors contributes to proteome plasticity.  Nat
Genet 2004, 36:1255-1257.
13. Akerman M, Mandel-Gutfreund Y: Alternative splicing regulation
at tandem 3' splice sites.  Nucleic Acids Res 2006, 34:23-31.
14. Hiller M, Huse K, Szafranski K, Jahn N, Hampe J, Schreiber S, Backofen
R, Platzer M: Single-nucleotide polymorphisms in NAGNAG
acceptors are highly predictive for variations of alternative
splicing.  Am J Hum Genet 2006, 78:291-302.
15. Tadokoro K, Yamazaki-Inoue M, Tachibana M, Fujishiro M, Nagao K,
Toyoda M, Ozaki M, Ono M, Miki N, Miyashita T, Yamada M: Fre-
quent occurrence of protein isoforms with or without a sin-
gle amino acid residue by subtle alternative splicing: the case
of Gln in DRPLA affects subcellular localization of the
products.  J Hum Genet 2005, 50:382-394.
16. Lorkovic ZJ, Lehner R, Forstner C, Barta A: Evolutionary conser-
vation of minor U12-type spliceosome between plants and
humans.  RNA 2005, 11:1095-1107.
17. Vogan KJ, Underhill DA, Gros P: An alternative splicing event in
the Pax-3 paired domain identifies the linker region as a key
determinant of paired domain DNA-binding activity.  Mol Cell
Biol 1996, 16:6677-6686.
18. Condorelli G, Bueno R, Smith RJ: Two alternatively spliced forms
of the human insulin-like growth factor I receptor have
distinct biological activities and internalization kinetics.  J Biol
Chem 1994, 269:8510-8516.
19. Wu S, Romfo CM, Nilsen TW, Green MR: Functional recognition
of the 3' splice site AG by the splicing factor U2AF35.  Nature
1999, 402:832-835.
20. Zhuang Y, Weiner AM: A compensatory base change in U1
snRNA suppresses a 5' splice site mutation.  Cell 1986,
46:827-835.
21. Sorek R, Shamir R, Ast G: How prevalent is functional alterna-
tive splicing in the human genome?  Trends Genet 2004,
20:68-71.
22. Kan Z, States D, Gish W: Selecting for functional alternative
splices in ESTs.  Genome Res 2002, 12:1837-1845.
23. Abril JF, Castelo R, Guigo R: Comparison of splice sites in mam-
mals and chicken.  Genome Res 2005, 15:111-119.
24. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F,
Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavy
K: Donor splice-site mutations in WT1 are responsible for
Frasier syndrome.  Nat Genet 1997, 17:467-470.
25. Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A,
Nagy M, Gaede KI, Franke A, Haesler R, et al.:  Sarcoidosis is
associated with a truncating splice site mutation in BTNL2.
Nat Genet 2005, 37:357-364.
26. Costa DB, Lozovatsky L, Gallagher PG, Forget BG: A novel splicing
mutation of the alpha-spectrin gene in the original heredi-
tary pyropoikilocytosis kindred.  Blood 2005, 106:4367-4369.
27. Nembaware V, Wolfe KH, Bettoni F, Kelso J, Seoighe C: Allele-spe-
cific transcript isoforms in human.  FEBS Lett 2004, 577:233-238.
28. Carmel I, Tal S, Vig I, Ast G: Comparative analysis detects
dependencies among the 5' splice-site positions.  RNA 2004,
10:828-840.
29. Yeo G, Burge CB: Maximum entropy modeling of short
sequence motifs with applications to RNA splicing signals.  J
Comput Biol 2004, 11:377-394.
30. Sorek R, Lev-Maor G, Reznik M, Dagan T, Belinky F, Graur D, Ast G:
Minimal conditions for exonization of intronic sequences: 5'
splice site formation in alu exons.  Mol Cell 2004, 14:221-231.
31. Roca X, Sachidanandam R, Krainer AR: Determinants of the
inherent strength of human 5' splice sites.  RNA 2005,
11:683-698.
32. Bi J, Xia H, Li F, Zhang X, Li Y: The effect of U1 snRNA binding
free energy on the selection of 5' splice sites.  Biochem Biophys
Res Commun 2005, 333:64-69.
33. Blencowe BJ: Exonic splicing enhancers: mechanism of action,
diversity and role in human genetic diseases.  Trends Biochem
Sci 2000, 25:106-110.R65.16 Genome Biology 2006,     Volume 7, Issue 7, Article R65       Hiller et al. http://genomebiology.com/2006/7/7/R65
Genome Biology 2006, 7:R65
34. Ladd AN, Cooper TA: Finding signals that regulate alternative
splicing in the post-genomic era.  Genome Biol 2002,
3:reviews0008.1-0008.16.
35. Graveley BR: Sorting out the complexity of SR protein
functions.  RNA 2000, 6:1197-1211.
36. Pozzoli U, Sironi M: Silencers regulate both constitutive and
alternative splicing events in mammals.  Cell Mol Life Sci 2005,
62:1579-1604.
37. Fairbrother WG, Yeh RF, Sharp PA, Burge CB: Predictive identifi-
cation of exonic splicing enhancers in human genes.  Science
2002, 297:1007-1013.
38. Zhang XH, Chasin LA: Computational definition of sequence
motifs governing constitutive exon splicing.  Genes Dev 2004,
18:1241-1250.
39. Yeo G, Hoon S, Venkatesh B, Burge CB: Variation in sequence
and organization of splicing regulatory elements in verte-
brate genes.  Proc Natl Acad Sci USA 2004, 101:15700-15705.
40. McCullough AJ, Berget SM: An intronic splicing enhancer binds
U1 snRNPs to enhance splicing and select 5' splice sites.  Mol
Cell Biol 2000, 20:9225-9235.
41. McCullough AJ, Berget SM: G triplets located throughout a class
of small vertebrate introns enforce intron borders and regu-
late splice site selection.  Mol Cell Biol 1997, 17:4562-4571.
42. Maquat LE: Nonsense-mediated mRNA decay: splicing, trans-
lation and mRNP dynamics.  Nat Rev Mol Cell Biol 2004, 5:89-99.
43. Reddy R, Henning D, Busch H: Pseudouridine residues in the 5'-
terminus of uridine-rich nuclear RNA I (U1 RNA).  Biochem
Biophys Res Commun 1981, 98:1076-1083.
44. Thomas J, Lea K, Zucker-Aprison E, Blumenthal T: The spliceo-
somal snRNAs of Caenorhabditis elegans.  Nucleic Acids Res 1990,
18:2633-2642.
45. Sorek R, Ast G: Intronic sequences flanking alternatively
spliced exons are conserved between human and mouse.
Genome Res 2003, 13:1631-1637.
46. Sugnet CW, Kent WJ, Ares M Jr, Haussler D: Transcriptome and
genome conservation of alternative splicing events in
humans and mice.  Pac Symp Biocomput 2004:66-77.
47. Sorek R, Shemesh R, Cohen Y, Basechess O, Ast G, Shamir R: A non-
EST-based method for exon-skipping prediction.  Genome Res
2004, 14:1617-1623.
48. Baek D, Green P: Sequence conservation, relative isoform fre-
quencies, and nonsense-mediated decay in evolutionarily
conserved alternative splicing.  Proc Natl Acad Sci USA 2005,
102:12813-12818.
49. Yeo GW, Van Nostrand E, Holste D, Poggio T, Burge CB: Identifi-
cation and analysis of alternative splicing events conserved in
human and mouse.  Proc Natl Acad Sci USA 2005, 102:2850-2855.
50. Kazan K: Alternative splicing and proteome diversity in
plants: the tip of the iceberg has just emerged.  Trends Plant Sci
2003, 8:468-471.
51. Iida K, Seki M, Sakurai T, Satou M, Akiyama K, Toyoda T, Konagaya
A, Shinozaki K: Genome-wide analysis of alternative pre-
mRNA splicing in Arabidopsis thaliana based on full-length
cDNA sequences.  Nucleic Acids Res 2004, 32:5096-5103.
52. Zhang H, Blumenthal T: Functional analysis of an intron 3' splice
site in Caenorhabditis elegans.  RNA 1996, 2:380-388.
53. Brackenridge S, Wilkie AO, Screaton GR: Efficient use of a 'dead-
end' GA 5' splice site in the human fibroblast growth factor
receptor genes.  EMBO J 2003, 22:1620-1631.
54. Crispino JD, Blencowe BJ, Sharp PA: Complementation by SR
proteins of pre-mRNA splicing reactions depleted of U1
snRNP.  Science 1994, 265:1866-1869.
55. Crispino JD, Sharp PA: A U6 snRNA:pre-mRNA interaction can
be rate-limiting for U1-independent splicing.  Genes Dev 1995,
9:2314-2323.
56. Chen JY, Stands L, Staley JP, Jackups RR Jr, Latus LJ, Chang TH: Spe-
cific alterations of U1-C protein or U1 small nuclear RNA
can eliminate the requirement of Prp28p, an essential DEAD
box splicing factor.  Mol Cell 2001, 7:227-232.
57. Hastings ML, Krainer AR: Pre-mRNA splicing in the new
millennium.  Curr Opin Cell Biol 2001, 13:302-309.
58. Automated Splice Site Analyses   [https://splice.cmh.edu/]
59. Nalla VK, Rogan PK: Automated splicing mutation analysis by
information theory.  Hum Mutat 2005, 25:334-342.
60. Kopelman NM, Lancet D, Yanai I: Alternative splicing and gene
duplication are inversely correlated evolutionary
mechanisms.  Nat Genet 2005, 37:588-589.
61. Echard A, Opdam FJ, de Leeuw HJ, Jollivet F, Savelkoul P, Hendriks
W, Voorberg J, Goud B, Fransen JA: Alternative splicing of the
human Rab6A gene generates two close but functionally dif-
ferent isoforms.  Mol Biol Cell 2000, 11:3819-3833.
62. Chern TM, van Nimwegen E, Kai C, Kawai J, Carninci P, Hayashizaki
Y, Zavolan M: A simple physical model predicts small exon
length variations.  PLoS Genet 2006, 2:e45.
63. Ray DW, Davis JR, White A, Clark AJ: Glucocorticoid receptor
structure and function in glucocorticoid-resistant small cell
lung carcinoma cells.  Cancer Res 1996, 56:3276-3280.
64. Rivers C, Levy A, Hancock J, Lightman S, Norman M: Insertion of an
amino acid in the DNA-binding domain of the glucocorticoid
receptor as a result of alternative splicing.  J Clin Endocrinol
Metab 1999, 84:4283-4286.
65. Hu CA, Lin WW, Obie C, Valle D: Molecular enzymology of
mammalian Delta1-pyrroline-5-carboxylate synthase. Alter-
native splice donor utilization generates isoforms with differ-
ent sensitivity to ornithine inhibition.  J Biol Chem 1999,
274:6754-6762.
66. Hinrichs AS, Karolchik D, Baertsch R, Barber GP, Bejerano G, Claw-
son H, Diekhans M, Furey TS, Harte RA, Hsu F, et al.: The UCSC
Genome Browser Database: update 2006.  Nucleic Acids Res
2006:D590-D598.
67. Splice-site Analyzer Tool   [http://ast.bioinfo.tau.ac.il/SpliceSite
Frame.htm]
68. MaxEntScan Splice Site Scores   [http://genes.mit.edu/burgelab/
maxent/Xmaxentscan_scoreseq.html]
69. Crooks GE, Hon G, Chandonia JM, Brenner SE: WebLogo: a
sequence logo generator.  Genome Res 2004, 14:1188-1190.
70. TAndem Splice Site DataBase   [http://helios.informatik.uni-
freiburg.de/TassDB/]